The shares were purchased at the public offering price of $15 per share.
EndoChoice is expected to realize $94.9 million in proceeds from the offering, including the proceeds from the option exercise.
EndoChoice’s stock is trading on the New York Stock Exchange under the symbol “GI.”
More articles on gastroenterology:
Consumerism is taking healthcare by storm: How is GI affected?
EndoChoice IPO update: Common stock price set at $15 per share
Frisbie Memorial Hospital begins to offer virtual colonoscopy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
